January 18, 2022 - HealthTimes

PSI’s Hormonal IUD’s Popularity Grows In Africa

January 18, 2022 Michael Gwarisa

A new study that was conducted by the Population Service International (PSI) to ascertain the profiles of women who choose to use the hormonal Intrauterine Device (IUD) method of contraception have revealed that most users continued using the method due to high levels of satisfaction. By Michael Gwarisa The study is titled Introducing the hormonal Intrauterine Device in Madagascar, Nigeria, and Zambia: results from a pilot study. The study was conducted by Kendal Danna, the PSI Sexual and Reproductive Health Technical Advisor together with her partners where a longitudinal study…

PrEP Uptake Still Very Low

January 18, 2022 Healthtimes

USE of daily oral pre-exposure prophylaxis (PrEP), is not expanding enough as was anticipated. HealthTimes Reporter According to the the Joint United Nations Programme on HIV/AIDS (UNAIDS) weekly report, the COVID-19 also had a negative impact on the uptake of the drug. “It has been more than a decade since the first evidence of the efficacy of daily oral pre-exposure prophylaxis (PrEP) was published. PrEP is now a valuable additional option for people who are at higher risk of acquiring HIV, and its global uptake has continued to increase, despite…

COVAX delivers its 1 billionth COVID-19 vaccine dose

January 18, 2022 Healthtimes

On 15 January 2022, a shipment of 1.1 million COVID-19 vaccines to Rwanda included the billionth dose supplied via COVAX. Own Correspondent Together with our partners, COVAX is leading the largest vaccine procurement and supply operation in history, with deliveries to 144 countries to date. But the work that has gone into this milestone is only a reminder of the work that remains. As of 13 January 2022, out of 194 Member States, 36 WHO Member States have vaccinated less than 10% of their population, and 88 less than 40%.…